SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-034387
Filing Date
2021-02-09
Accepted
2021-02-09 16:21:00
Documents
5
Period of Report
2021-02-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d117998d8k.htm 8-K 22347
2 EX-3.1 d117998dex31.htm EX-3.1 26751
3 EX-3.2 d117998dex32.htm EX-3.2 114018
4 EX-99.1 d117998dex991.htm EX-99.1 6726
5 GRAPHIC g117998dsp001.jpg GRAPHIC 12693
  Complete submission text file 0001193125-21-034387.txt   188675
Mailing Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39979 | Film No.: 21606712
SIC: 2836 Biological Products, (No Diagnostic Substances)